SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 79.54 |
| Enterprise Value ($M) | 69.04 |
| Book Value ($M) | 34.63 |
| Book Value / Share | 3.98 |
| Price / Book | 2.30 |
| NCAV ($M) | 34.63 |
| NCAV / Share | 3.98 |
| Price / NCAV | 2.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.54 |
| Return on Assets (ROA) | -2.33 |
| Return on Equity (ROE) | -3.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.78 |
| Current Ratio | 9.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 38.58 |
| Assets | 38.58 |
| Liabilities | 3.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.74 |
| Operating Income | -18.23 |
| Net Income | -16.29 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.53 |
| Cash from Investing | -28.66 |
| Cash from Financing | 46.40 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | AWM Investment Company, Inc. | 9.90 | 113.05 | |
| 13G/A | Ra Capital Management, L.p. | 9.90 | 10.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 60,620 | 284,601 | 21.30 | |
| 71,302 | 269,879 | 26.42 | |
| 51,387 | 202,138 | 25.42 | |
| 113,616 | 416,950 | 27.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRBP – Corbus Pharmaceuticals Holdings, Inc. | CRDF – Cardiff Oncology, Inc. |
| CRIS – Curis, Inc. | CSBR – Champions Oncology, Inc. |
| CSCI – COSCIENS Biopharma Inc. |
Financial data and stock pages provided by
Fintel.io